0
0 (0%)
Emmaus Life Sciences, Inc. [EMMA]
Source:
Company Overview
Emmaus Life Sciences, Inc is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, primarily for rare and orphan diseases.
| Country | United States |
| Headquarters | torrance, california |
| Phone Number | 310-214-0065 |
| Industry | manufacturing |
| CEO | Yutaka Niihara |
| Website | www.emmausmedical.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $5.5 |
| Operating Profit | $0.8 |
| Net Income | $1.8 |
| Net Cash | $-1.3 |
Profit Ratios
| Gross Margin | $5.1 |
| Operating Margin | 15 |
| Profit as % of Revenues | 278.3% |
| Profit as % of Assets | 11.1% |
| Profit as % of Stockholder Equity | -3.4% |
Management Effectiveness
| Return on Equity | -3.4% |
| Return on Assets | 6.7% |
| Turnover Ratio | 33.4% |
| EBITA | $0.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $27.3 |
| Total Liabilities | $81.1 |
| Operating Cash Flow | $-2.6 |
| Investing Cash Flow | $2.5 |
| Financing Cash Flow | $-1.2 |
